Anti-Vegf Therapy for Ocular Diseases: Present and Future

Curr Drug Targets. 2020;21(12):1158. doi: 10.2174/138945012112200727153907.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Eye Diseases / drug therapy*
  • Humans
  • Neovascularization, Pathologic
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*

Substances

  • Angiogenesis Inhibitors
  • Vascular Endothelial Growth Factor A